BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23271907)

  • 1. Biocompatible nanocomposite for PET/MRI hybrid imaging.
    Locatelli E; Gil L; Israel LL; Passoni L; Naddaka M; Pucci A; Reese T; Gomez-Vallejo V; Milani P; Matteoli M; Llop J; Lellouche JP; Franchini MC
    Int J Nanomedicine; 2012; 7():6021-33. PubMed ID: 23271907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.
    Truillet C; Bouziotis P; Tsoukalas C; Brugière J; Martini M; Sancey L; Brichart T; Denat F; Boschetti F; Darbost U; Bonnamour I; Stellas D; Anagnostopoulos CD; Koutoulidis V; Moulopoulos LA; Perriat P; Lux F; Tillement O
    Contrast Media Mol Imaging; 2015; 10(4):309-19. PubMed ID: 25483609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
    Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
    Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging.
    Fernández-Barahona I; Ruiz-Cabello J; Herranz F; Pellico J
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.
    Karageorgou MA; Vranješ-Djurić S; Radović M; Lyberopoulou A; Antić B; Rouchota M; Gazouli M; Loudos G; Xanthopoulos S; Sideratou Z; Stamopoulos D; Bouziotis P; Tsoukalas C
    Contrast Media Mol Imaging; 2017; 2017():6951240. PubMed ID: 29445321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary studies of
    Lahooti A; Shanehsazzadeh S; Laurent S
    Nanotechnology; 2020 Jan; 31(1):015102. PubMed ID: 31519003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging.
    Yang BY; Moon SH; Seelam SR; Jeon MJ; Lee YS; Lee DS; Chung JK; Kim YI; Jeong JM
    Nanomedicine (Lond); 2015 Jul; 10(12):1899-910. PubMed ID: 26139125
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bouziotis P; Stellas D; Thomas E; Truillet C; Tsoukalas C; Lux F; Tsotakos T; Xanthopoulos S; Paravatou-Petsotas M; Gaitanis A; Moulopoulos LA; Koutoulidis V; Anagnostopoulos CD; Tillement O
    Nanomedicine (Lond); 2017 Jul; 12(13):1561-1574. PubMed ID: 28621567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid core shell nanoparticles entrapping Gd-DTPA and
    Vecchione D; Aiello M; Cavaliere C; Nicolai E; Netti PA; Torino E
    Nanomedicine (Lond); 2017 Sep; 12(18):2223-2231. PubMed ID: 28814136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shell.
    Israel LL; Kovalenko EI; Boyko AA; Sapozhnikov AM; Rosenberger I; Kreuter J; Passoni L; Lellouche JP
    Nanotechnology; 2015 Jan; 26(4):045601. PubMed ID: 25556693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging.
    Chakravarty R; Valdovinos HF; Chen F; Lewis CM; Ellison PA; Luo H; Meyerand ME; Nickles RJ; Cai W
    Adv Mater; 2014 Aug; 26(30):5119-23. PubMed ID: 24944166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of
    Körhegyi Z; Rózsa D; Hajdu I; Bodnár M; Kertész I; Kerekes K; Kun S; Kollár J; Varga J; Garai I; Trencsényi G; Borbély J
    Anticancer Res; 2019 May; 39(5):2415-2427. PubMed ID: 31092434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
    Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
    Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
    [No Abstract]   [Full Text] [Related]  

  • 15. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
    Fani M; André JP; Maecke HR
    Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and
    Polyak A; Naszalyi Nagy L; Mihaly J; Görres S; Wittneben A; Leiter I; Bankstahl JP; Sajti L; Kellermayer M; Zrínyi M; Ross TL
    J Pharm Biomed Anal; 2017 Apr; 137():146-150. PubMed ID: 28119212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
    Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
    Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
    Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
    Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga.
    Ramogida CF; Pan J; Ferreira CL; Patrick BO; Rebullar K; Yapp DT; Lin KS; Adam MJ; Orvig C
    Inorg Chem; 2015 May; 54(10):4953-65. PubMed ID: 25928800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.